Today: 12 May 2026
US Stock Market (After Hours): Dow, S&P 500, Nasdaq Slide as Iran Risk Overtakes Earnings
21 April 2026
2 mins read

US Stock Market (After Hours): Dow, S&P 500, Nasdaq Slide as Iran Risk Overtakes Earnings

NEW YORK, April 21, 2026, 04:26 PM EDT

  • Early momentum fizzled for U.S. stocks, leaving the S&P 500, Nasdaq, and Dow all roughly 0.6% in the red by the close.
  • Brent crude jumped 3.1%, with jitters around U.S.-Iran negotiations feeding fresh energy risk into the market.
  • UnitedHealth gave the Dow a lift with better-than-expected results, but news of a CEO change at Apple dragged on the megacaps.

Wall Street slipped on Tuesday, erasing early gains as renewed worries over U.S.-Iran peace talks pushed oil prices higher and undercut the session’s earnings-driven momentum. The S&P 500 dropped roughly 0.63% to finish at 7,064, with the Nasdaq Composite off 0.59% at around 24,260. The Dow Jones Industrial Average declined about 293 points, or 0.59%, closing near 49,149, according to preliminary figures.

This shift matters because Wall Street had been steadying itself on two main hopes: a continued easing in the Middle East conflict, plus an early batch of first-quarter numbers that were looking less bad than many had braced for. By the closing bell, though, oil was the obvious play. Brent crude gained $3, up 3.1%, to finish at $98.48 a barrel. U.S. crude settled at $92.13. Saad Rahim, Trafigura’s chief economist, pointed out the market had already “lost a billion barrels” even in a scenario where the crisis gets resolved swiftly. Reuters

Stocks sold off more sharply once word spread that Vice President JD Vance’s planned visit to Pakistan was paused. Traders also noted that Iran hadn’t said yes to a second meeting with Washington. For Thomas Martin at GLOBALT Investments, there’s no sugarcoating it: the “wild card is indeed what happens with Iran.” Reuters

Bears didn’t get much clear ammunition from the latest economic numbers. U.S. retail and food services sales climbed 1.7% in March, reaching $752.1 billion, according to the Census Bureau. Those numbers, though, aren’t inflation-adjusted—so pricier gas can inflate the total even if actual sales volumes barely budge.

Rising rates piled on pressure. The 10-year Treasury yield climbed as investors reacted to upbeat retail sales data and kept close tabs on Kevin Warsh’s confirmation hearing for the Federal Reserve’s top job. Mark Hackett of Nationwide Investment Management Group described the session as “softening and rates rising,” pointing to renewed uncertainty around the Fed’s balance sheet and policy trajectory. Reuters

Some relief came from earnings. UnitedHealth jumped roughly 7% after the insurer topped Wall Street’s estimates for both earnings and revenue and bumped up its full-year profit guidance. “Margins are improving,” said Brian Mulberry, chief market strategist at Zacks Investment Management. Oppenheimer’s Michael Wiederhorn said the latest numbers should “support the group.” Reuters

AI continued to drive bullish sentiment. Amazon announced plans to pour as much as $25 billion into Anthropic, locking in a commitment from the startup to spend upwards of $100 billion on Amazon’s cloud over the next decade. Amazon shares saw gains in late trading on the news.

J.P. Morgan bumped its S&P 500 year-end target up to 7,600, pointing to AI and tech-fueled earnings growth. Still, the firm flagged a potential “short-term consolidation phase,” noting that geopolitical uncertainty hasn’t gone away. Reuters

Apple lagged behind other megacaps after announcing that hardware chief John Ternus will take over from Tim Cook as CEO on Sept. 1. But succession isn’t the only issue in play. The bigger test: Apple is under pressure to prove it can make up ground in AI—Nvidia is still out in front by market cap, Google’s Gemini is now powering Siri, and Meta is moving forward on its hardware ambitions. Bob O’Donnell at TECHnalysis Research called Ternus’ main hurdle “building a better AI story.” Reuters

The risk is straightforward. Should the ceasefire effort collapse, crude pushing toward $100 would squeeze transport costs, margins, and household budgets all over again. But a return to talks might see some of Tuesday’s defensive trades reverse in a hurry. So a session that opened on earnings closed with attention shifting back to diplomacy, oil prices, and the Fed.

Stock Market Today

  • QuantumScape Shares Rise 9.35% After Q1 Earnings Beat Expectations
    May 12, 2026, 5:51 PM EDT. QuantumScape Corporation (NASDAQ: QS) shares jumped 9.35% following its Q1 2026 earnings report, which showed a smaller-than-expected loss of $0.16 per share versus Wall Street's forecast of $0.18. Despite continuing losses of $100.8 million driven by heavy R&D spending, QS's strong cash position of $904.7 million and a working capital cushion of $872.1 million reassure investors. The stock's advance from mid-$6s in late April to around $8.26 on May 11 reflects growing optimism about the firm's solid-state lithium-metal battery technology. Market participants remain focused on progress toward commercialization, with robust trading momentum indicating confidence in QS's potential for electric vehicle applications.

Latest article

British American Tobacco Stock Jumps as FDA Shift Gives Vuse and Velo a Cleaner Read

British American Tobacco Stock Jumps as FDA Shift Gives Vuse and Velo a Cleaner Read

12 May 2026
British American Tobacco shares jumped 5.82% in London to £46.34 after the FDA signaled a softer enforcement stance on some e-cigarette and nicotine pouch products. A U.S. judge also dismissed BAT’s North Korea sanctions case following a $630 million settlement. The FTSE 100 slipped 0.04%. BAT’s U.S.-listed ADR closed up 5.3% at $63.64.
Camtek Stock Falls 16% After Earnings Beat as Margin Pressure and Hot CPI Hit AI Chip Trade

Camtek Stock Falls 16% After Earnings Beat as Margin Pressure and Hot CPI Hit AI Chip Trade

12 May 2026
Camtek shares fell 15.8% to $174.63 despite beating Q1 revenue and adjusted EPS estimates by small margins. Q1 revenue rose 2.5% year over year, but non-GAAP EPS dropped to $0.70 from $0.79 and operating margin narrowed to 25.5%. Management guided Q2 revenue to $129–$131 million and expects second-half revenue to rise over 25%. Broader market pressure followed a hot April CPI and rising Treasury yields.
Oscar Health stock rises in premarket after 2026 revenue outlook; House subpoenas add a fresh risk

Oscar Health Stock Extends Post-Earnings Repricing as Margins Outweigh ACA Risk

12 May 2026
Oscar Health shares rose 7.9% to $23.73 late Tuesday, with volume near 13 million, after posting strong Q1 profit and lower claims costs despite missing revenue estimates. The company’s medical loss ratio fell to 70.5% from 75.4% a year earlier. Membership climbed to 3.17 million. ACA enrollment churn and policy risk remain concerns.
XRP Price Today: Why the $1.42 Level Matters as Bitcoin Fund Flows Return
Previous Story

XRP Price Today: Why the $1.42 Level Matters as Bitcoin Fund Flows Return

FTSE 100 Today: Why London Stocks Are Stuck Near 10,500 as Inflation Bites
Next Story

FTSE 100 Today: Why London Stocks Are Stuck Near 10,500 as Inflation Bites

Go toTop